Four Injectafer Lawsuits To Go Before Juries For Trial Dates Set to Begin in 2023
A federal judge has scheduled three Injectafer lawsuits to go to trial throughout 2023.
A federal judge has scheduled three Injectafer lawsuits to go to trial throughout 2023.
The FDA is warning doctors not to prescribe Hospira potassium phosphate injections to infants, due to the risk of aluminum toxicity.
A woman has filed a product liability lawsuit indicating she suffered dangerous drops in blood phosphorous levels due to Injectafer iron deficiency infusions.
An Injectafer lawsuit alleges two iron injections to combat anemia led to critically low phosphorous levels, pain, nausea, fatigue, weakness and other ailments.
An Injectafer lawsuit claims the iron deficiency treatment caused a woman to suffer dangerously low blood phosphate levels due to the manufacturers' failure to warn of the drug's risks.
Injectafer iron infusion side effects led to critically low blood phosphorus levels which led to severe and permanent injuries, according to a recently filed lawsuit.
A Brooklyn man says he now suffers a host of Injectafer long-term side effects following a series of injections of the iron infusion drug.
A product liability lawsuit claims the Injectafer warning label downplayed the health risks of severe HPP.
A Philadelphia woman's Injectafer lawsuit will be the first bellwether trial and will go before a jury in June 2023.
An Injectafer lawsuit indicates repeated iron infusion injections left a New York woman debilitated and with serious injuries.